Reflection versus Rebreathing for Administration of Sevoflurane during minor gynaecological surgery

Reflection versus Rebreathing for Administration of Sevoflurane during minor gynaecological surgery - ReVeRAS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016008

Enrollment

Registered

2019-04-03

Start date

2019-04-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

minor gynaecological surgery

Interventions

Group 1: Group RF: Use of an anaesthetic reflector (AnaConDa-S, Sedana Medical, Stockholm, Sweden) in combination with a syringe pump (Braun Space, Melsungen, Germany) to deliver sevoflurane Group 2:

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: elective gynaecological surgery under general anaesthesia with an indication for endotracheal intubation

Exclusion criteria

Exclusion criteria: -Surgery with pneumoperitoneum, -More extensive surgery associated with high blood loss, circulatory instability or postoperative sedation and ventilation on the ICU -Indication for total intravenous anaesthesia

Design outcomes

Primary

Measure	Time frame
Consumption of sevoflurane in ml per MAC-hour	—

Secondary

Measure	Time frame
T-in: wash in of sevoflurane, time to reach the target concentration (0,5MAC) for the first time and exceed it for at least 30 seconds T-50: wash out of sevoflurane, time from stop of delivery to reach 50% of the initial concentration	—

Countries

Germany

Contacts

Public ContactAndreas Meiser

Universitätsklinikum des Saarlandes Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Geb. 57

andreas.meiser@uks.eu06841/1630001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026